(?)MDPV failed to change ICSS at doses around one hundred times higher than that of the lowest statistically major successful dose of SAlso, drug makers can easily skirt the ban on MDPV and mephedrone by turning to other cathinone derivatives, of which there are numerous.Methylenedioxypyrovalerone features a report of FDA-permitted healthcare use.